Find and Pitch Jounalists, Get Your Story Covered

Tags: biotechnology CRISPR drug development FDA Pharmaceuticals

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Biotechs emerging from stealth take aim at pharma’s prime targets - 11 days ago California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - 6 months ago Who’s winning in biotech’s tight market? - 7 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 7 months ago PharmaVoice 100s: Entrepreneurs - over 1 year ago
2	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	How the race for the next obesity drug is shaping up - 30 days ago The view from overseas on tumult in U.S. science - about 2 months ago The biotech news stories you need to read today - about 2 months ago The biotech news stories we’re keeping an eye on - 3 months ago Merck is a new year outlier with its diabetes drug - 3 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 10 months ago How resurrecting extinct species might impact medicine - 12 months ago Lawmakers want to add more Chinese biotechs to defense list - about 1 year ago The Senate health committee looks into its first subpoena in 40 years - about 1 year ago The biotech updates you need to read today - over 1 year ago The legal pathway for experimental, ultra-rare disease treatments is rocky and expensive - over 1 year ago The biotech news you missed from the weekend - over 1 year ago Novartis is building a new radioligand plant in China - over 1 year ago Johnson & Johnson bets heavy on AI-driven drug discovery - over 1 year ago A new algorithm unveils CRISPR ‘treasure trove’ - over 1 year ago These are the need-to-know biotech stories from this weekend - over 1 year ago The first vaccine for the increasingly prevalent chikungunya virus is here - over 1 year ago XBI biotech index rises, giving investors a shred of hope - over 1 year ago Want a biotech buyout? Target cancer - over 1 year ago
3	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Biotech is in a dark place - about 2 months ago STAT+: Biotech companies detail emerging efforts to ease ‘conditioning’ before genetic treatments - 4 months ago A biotech’s binary bet ends badly - 10 months ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Is Trump’s new order a reprieve for biotech? - about 2 months ago East Asians under-represented in biopharma leadership - 3 months ago Can an epilepsy drug do more than reduce seizures? - 3 months ago STAT+: 3 trends to watch in biotech in 2025 - 3 months ago A key decision on compounding is expected this week - 4 months ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - about 2 months ago Milk-based therapies could be coming. This biotech CEO is aiming to lead the way. - 4 months ago Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 8 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 8 months ago The hunt for the brain’s biomarkers - 10 months ago 4 offbeat biotechs making a splash in the life sciences - 11 months ago These biotech hotspots are ripe for IPOs - about 1 year ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More - 3 months ago AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots - 4 months ago
7	Jessica Rendall CNET Journalist/Presenter @abcdarwin. Brisbane JournalismBroadcasting	Tech and Wellness Will Combine Like Never Before in 2025, but Will We Benefit? - 3 months ago
8	STAT Staff STAT News Frontiers of health & medicine reporting. healthmedicinejournalism	STAT stories you might have missed in 2024 - 3 months ago STAT+: Biotech analyst Brian Skorney and CEO Daphne Zohar weigh in on election results - 5 months ago
9	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - 5 months ago 2024 PharmaVoice 100s: Biotech Pathfinders - 5 months ago 23andMe inches closes to cancer immunotherapy, guided by its genetic database - 8 months ago A biotech dousing ‘fires’ in the brain that plagued a bestselling author - 8 months ago Protein power: a biotech mining viruses to fight disease - 9 months ago Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections - 9 months ago 3 up-and-coming US biotech hotspots - 11 months ago Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - 12 months ago An ocean of answers in a single cell — how proteomics can lead to better drugs - about 1 year ago How to make 2024 a banner year for biopharma, despite the headwinds - about 1 year ago One biotech’s 3 gene therapy hurdles: delivery, delivery and delivery - about 1 year ago This biotech aims to expand the CRISPR toolkit for more disease targets in the liver and brain - over 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago The thorniest questions facing pharma, according to a leading bioethicist - over 1 year ago
10	Mario Aguilar STAT News Reporter at STATnews. Previous engagements noted. Personal views. Brooklyn techhealth care	The GLP-1 telehealth boom, Senate investigation of MA plans, and the fall of a cancer startup - 6 months ago STAT+: AI leads the way as health tech funding inches toward a post-pandemic stability - 9 months ago

Journalists covering biotech & health